Cumberland Pharmaceuticals Inc. (CPIX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 387.02K | 3.02K | 187.18K | 843.8K | 3.9M | 1.9M | 475.5K | -855.66K | -2.14M | 1.04M | 1.24M | 5.24M |
| Operating CF Margin % | 4.24% | 0.02% | 2.26% | 7.79% | 33.28% | 18.25% | 5.23% | -8.69% | -25.14% | 11.12% | 12.26% | 48.08% |
| Operating CF Growth % | -90.07% | -99.84% | -60.64% | 198.61% | 282.46% | 83.12% | -61.55% | -116.34% | -50.66% | -63.43% | -63.94% | 124.64% |
| Net Income | -3.29M | -1.43M | -1.94M | -740.74K | 1.25M | -1.9M | -1.54M | -1.1M | -1.9M | -6.3M | -1.06M | 862.15K |
| Depreciation & Amortization | 1.56M | 1.33M | 1.04M | 1.32M | 1.32M | 1.78M | 1.4M | 1.42M | 1.44M | 2.07M | 1.49M | 1.5M |
| Stock-Based Compensation | 106.84K | 172.16K | 0 | 80.69K | 74.21K | 74.81K | 76.37K | 71.96K | 78.75K | 93.89K | 83.11K | 97.88K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 9.24K | -37.3K | 281.72K | -1.49M | 131.52K | -475.67K | -1.93M | -179.37K | -355.84K | 2.99M | -771.65K | 1.58M |
| Working Capital Changes | 2M | -30.27K | 808.42K | 1.68M | 1.13M | 2.43M | 2.46M | -1.07M | -1.39M | 2.19M | 1.5M | 1.2M |
| Change in Receivables | 2.68M | -6.51M | -113.69K | 171.01K | 1.21M | -390.84K | 309.14K | -795.18K | -1.07M | 2.51M | -54.56K | 463.31K |
| Change in Inventory | 703.86K | -205.99K | 630.41K | 850.8K | 967.4K | 1.34M | -170.95K | 1.07M | 170.47K | -441.5K | 650.47K | 91.45K |
| Change in Payables | -1.35M | 8.04M | 684.22K | 0 | -600.04K | 2.45M | 1.26M | -1.28M | -645.54K | 1.82M | 1.52M | 1.49M |
| Cash from Investing | -61.17K | -3.07M | -690.84K | 285.86K | -1.23M | -26.81K | 189.64K | -46.8K | -58.19K | 260.64K | -95.07K | -96.81K |
| Capital Expenditures | 0 | 1 | -32.24K | -26.49K | -47.63K | -2.28K | 40.81K | -7.18K | -41.62K | -48.67K | -53.14K | -72.19K |
| CapEx % of Revenue | 0% | 0% | 0.39% | 0.24% | 0.41% | 0.02% | 0.45% | 0.07% | 0.49% | 0.52% | 0.53% | 0.66% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -61.17K | -43.84K | -47K | 312.35K | -1.18M | -24.53K | 148.83K | -39.63K | -16.57K | 309.31K | -41.93K | -24.61K |
| Cash from Financing | -763.3K | -681.74K | -386.88K | -150.8K | -5.53M | -1.38M | -536.84K | -309.57K | 2.42M | -1.49M | -882.6K | -3.28M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | -10.04M | -815.42K | 0 | 7.45K | 3.3M | -138.98K | -225K | -2.92M |
| Equity Issued (Net) | -61K | 0 | -10.44K | -7.17K | -245.87K | -98.38K | -98.81K | -134.25K | -247.6K | -188.97K | -201.65K | -162.79K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -61K | 0 | -10.44K | -7.17K | -245.87K | -98.38K | -98.81K | -134.25K | -247.6K | -188.97K | -201.65K | -162.79K |
| Other Financing | -702.3K | -681.74K | -376.44K | -143.63K | 4.76M | -464.57K | -438.02K | -182.78K | -630.7K | -1.16M | -455.94K | -188.68K |
| Net Change in Cash | -437.45K | -3.75M | -890.54K | 978.87K | -2.86M | 499.43K | 128.31K | -1.21M | 226.86K | -186.34K | 258.88K | 1.86M |
| Free Cash Flow | 387.02K | -40.82K | 163.39K | 817.32K | 3.85M | 1.88M | 516.32K | -902.46K | -2.19M | 953.4K | 1.14M | 5.14M |
| FCF Margin % | 4.24% | -0.3% | 1.97% | 7.54% | 32.88% | 17.99% | 5.68% | -9.16% | -25.83% | 10.19% | 11.32% | 47.19% |
| FCF Growth % | -89.95% | -102.17% | -68.35% | 190.56% | 275.45% | 96.96% | -54.77% | -117.56% | -37.81% | -52.26% | -52.77% | 138.12% |
| FCF per Share | 0.03 | -0.00 | 0.01 | 0.05 | 0.25 | 0.13 | 0.04 | -0.06 | -0.16 | 0.07 | 0.08 | 0.35 |
| FCF Conversion (FCF/Net Income) | -0.12x | -0.00x | -0.10x | -1.14x | 3.10x | -1.00x | -0.31x | 0.79x | 1.10x | -0.17x | -1.18x | 6.00x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |